Literature DB >> 11274364

p19ARF targets certain E2F species for degradation.

F Martelli1, T Hamilton, D P Silver, N E Sharpless, N Bardeesy, M Rokas, R A DePinho, D M Livingston, S R Grossman.   

Abstract

p19ARF suppresses the growth of cells lacking p53 through an unknown mechanism. p19ARF was found to complex with transcription factors E2F1, -2, and -3. Levels of endogenous or ectopically expressed E2F1, -2, and -3, but not E2F6, were reduced after synthesis of p19ARF, through a mechanism involving increased turnover. p19ARF-induced degradation of E2F1 depended on a functional proteasome, and E2F1 was relocalized to nucleoli when coexpressed with p19ARF. Consistent with reduced levels of E2F1 and E2F3, the proliferation of cells defective for p53 function was suppressed by p19ARF, and the effect was partially reversed by ectopic overexpression of E2F1. These results suggest a broader role for p19ARF as a tumor suppressor, in which targeting of certain E2F species may cooperate with stimulation of the p53 pathway to counteract oncogenic growth signals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274364      PMCID: PMC31856          DOI: 10.1073/pnas.081061398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

Authors:  T F Kowalik; J DeGregori; G Leone; L Jakoi; J R Nevins
Journal:  Cell Growth Differ       Date:  1998-02

2.  A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

Authors:  D S Ory; B A Neugeboren; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Binding and modulation of p53 by p300/CBP coactivators.

Authors:  N L Lill; S R Grossman; D Ginsberg; J DeCaprio; D M Livingston
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

4.  Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

Authors:  G Hateboer; R M Kerkhoven; A Shvarts; R Bernards; R L Beijersbergen
Journal:  Genes Dev       Date:  1996-12-01       Impact factor: 11.361

5.  The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.

Authors:  F Hofmann; F Martelli; D M Livingston; Z Wang
Journal:  Genes Dev       Date:  1996-12-01       Impact factor: 11.361

6.  Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.

Authors:  M R Campanero; E K Flemington
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.

Authors:  L Chin; J Pomerantz; D Polsky; M Jacobson; C Cohen; C Cordon-Cardo; J W Horner; R A DePinho
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

8.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

9.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

10.  Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins.

Authors:  W T Steegenga; T Van Laar; A Shvarts; C Terleth; A J Van der Eb; A G Jochemsen
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

View more
  55 in total

1.  Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.

Authors:  Abhishek Datta; Alo Nag; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.

Authors:  Harry A Rogoff; Mary T Pickering; Michelle E Debatis; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

3.  APC/C(Cdc20) targets E2F1 for degradation in prometaphase.

Authors:  Melissa J Peart; Masha V Poyurovsky; Elizabeth M Kass; Marshall Urist; Emmy W Verschuren; Matthew K Summers; Peter K Jackson; Carol Prives
Journal:  Cell Cycle       Date:  2010-10-26       Impact factor: 4.534

4.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation.

Authors:  Alessandra Magenta; Pasquale Fasanaro; Sveva Romani; Valeria Di Stefano; Maurizio C Capogrossi; Fabio Martelli
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

6.  Rbf1 degron dysfunction enhances cellular DNA replication.

Authors:  Nitin Raj; Liang Zhang; Yiliang Wei; David N Arnosti; R William Henry
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

7.  ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Authors:  Linan Ha; Takeshi Ichikawa; Miriam Anver; Ross Dickins; Scott Lowe; Norman E Sharpless; Paul Krimpenfort; Ronald A Depinho; Dorothy C Bennett; Elena V Sviderskaya; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

Review 10.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.